red spot at tirzepatide injection site How to Inject Zepbound: How & Where to Administer Zepbound Injection Site Reactions with Tirzepatide:

Some individuals may experience more significant weight loss, while others may see more gradual results

Insulin and blood sugar

Patients with diabetic retinopathy should be monitored for complications during rapid improvements in glucose control

So far, studies have reported: Phase 2 (48 weeks): up to 24.2% average weight loss Phase 3 TRIUMPH-4 topline (68 weeks): 28.7% average weight loss (press release) What that looks like: If you start at 100 kg : 24.2% 24 kg average loss 28.7% 29 kg average loss Side effects and safety signals (what we know so far) Phase 2 (peer-reviewed) In the phase 2 trial, the most common adverse events were gastrointestinal and dose-related, typically mild to moderate